Secondary outcomes included GLP-1-related complications (acute pancreatitis, gastroparesis, abnormal weight loss) and postoperative events (acute kidney injury (AKI), myocardial infarction (MI), transient ischemic attack (TIA), cerebral infarction, arrhythmia, and hypoglycemic events). This evidence concerns the gene GLP1R and cerebral infarction.